| Cash Flow | 2026-04-30 | 2025-04-30 |
|---|---|---|
| Net income (loss) | 9,213 | 93,582 |
| Depreciation and amortization expense | 42,602 | 35,373 |
| Stock-based compensation | 10,768 | 13,689 |
| Impairment loss | 5,089 | 1,247 |
| Loss on disposal of property and equipment | -2,323 | -1,130 |
| Deferred income taxes | -656 | 7,088 |
| Net losses (gains) on investment in marketable securities | -3,751 | 1,398 |
| Net gains on derivative instruments | 9,409 | 3,987 |
| Shares issued to an employee in lieu of cash compensation | 491 | 1,589 |
| Income tax expense related to write-down of long-term deposits | 5,908 | - |
| Other noncash | -51 | -1,327 |
| Accounts and other receivables | 17,634 | -17,616 |
| Merchandiseinventories | -1,215 | -37,179 |
| Textbookrentalinventories | 596 | 21,281 |
| Prepaid expenses and other current assets | 7,006 | -5,039 |
| Changes in lease right-of-use assets and liabilities | 12,875 | -18,071 |
| Long-term deposits | -52 | -61 |
| Other assets | -9,024 | 25,339 |
| Accounts payable and accrued liabilities | 7,708 | -188,998 |
| Other current liabilities | -30 | -7,774 |
| Deferred revenue | -3,311 | -9,222 |
| Other long-term liabilities | -13,362 | 3,574 |
| Net cash flows provided by (used in) operating activities | 59,066 | -57,576 |
| Purchases of marketable securities and other investments | 62,740 | 101,988 |
| Proceeds from sale or maturities of marketable securities and other investments | 118,907 | 138,885 |
| Proceeds from sale of derivative instruments | 24,148 | 16,851 |
| Payments for settlement of derivative instruments | 12,618 | 8,549 |
| Acquisition of business net of cash acquired | 0 | 31,379 |
| Purchase of property and equipment | 16,196 | 11,237 |
| Proceeds from disposal of property and equipment | 0 | 792 |
| Net cash flows provided by (used in) investing activities | 51,501 | 3,375 |
| Proceeds from borrowings | 812,900 | 836,153 |
| Repayment of borrowing | 845,000 | 834,290 |
| Proceeds from sale of barnes & noble education common stock, net of commissions and issuance costs | 0 | 78,061 |
| Payment of deferred financing costs | 1,900 | - |
| Dividend payments to stockholders | 8,050 | 12,854 |
| Proceeds from stock options exercises | - | 0 |
| Payment for purchases of treasury stock | 10 | 2,376 |
| Shares withheld to cover payroll taxes | 2,329 | 3,741 |
| Other financing activities | - | 0 |
| Payment of finance lease principal | 365 | - |
| Net cash flows provided by (used in) financing activities | -44,754 | 60,953 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 65,813 | 6,752 |
| Beginning of period | 92,273 | 85,521 |
| End of period | 158,086 | 92,273 |
IMMERSION CORP (IMMR)
IMMERSION CORP (IMMR)